ExploreWatchlistsPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Inventories

WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)

Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndInventories (Million JPY)YoY (%)
Mar 31, 20262,619+33.39%
Mar 31, 20251,964+90.49%
Mar 31, 20241,031+4.12%
Mar 31, 2023990-20.81%
Mar 31, 20221,250+17.22%
Mar 31, 20211,067-24.38%
Mar 31, 20201,411+2.25%
Mar 31, 20191,380+6.56%
Mar 31, 20181,295-15.38%
Mar 31, 20171,530-12.31%
Mar 31, 20161,745+37.59%
Mar 31, 20151,268

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat